We are live on ! Find out more

MEDS

DataMeds AI

MEDS

Market cap $2.76M

0.9001 USD

+0.0081

0.91%

At close Updated Sep 11, 4:00 PM EDT

1 day

0.91%

5 days

-7.68%

1 month

-35.24%

3 months

-75.8%

6 months

-90.61%

Year to date

-95.85%

1 year

-98.82%

5 years

-99.53%

10 years

-99.53%

About: DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.

Healthcare Medical Distribution

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App TAMPA, FL / ACCESS Newswire / September 8, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™,and Tollo Health, LLC ("Tollo"), a proprietary medical foods and nutraceutical manufacturer, today announced they have jointly entered into a partnership with the National Football League Alumni Association, Inc. through its Alumni Health subsidiary ("NFLAH"). This partnership, supported by DataMEDS' pharmacy-focused subsidiary Corexa Health's network of over 6,500 independent pharmacies, aims to provide underserved and rural communities with increased awareness around healthy living, better access to discounted pharmacy services, improved control over patient data and access to pharmacy-based services and unique products.

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

Revenues grew 14% reaching $1.779M in Q2/26, beating management projections Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from ‘WGRX' to ‘MEDS' on NASDAQ Capital Markets $6.5 million new funding in June 2026 provided capital to support corporate turnaround Pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate patent protected blockchain, biometrics and pharmaceutical-adjunct products intellectual properties to deliver the "Health Lives Here" consumer app, in partnership with NFL Alumni Health (NFLAH), to deliver an effective healthcare experience to patients in rural communities via local independent pharmacies 1:50 reverse split in May 2026 implemented to partially address NASDAQ delisting risk Holders of 1,533,930 common shares, representing ~49% of shares outstanding, have entered into lock-up agreements for at least an additional ninety (90) days Dream Bowl Meme Coin I token distribution Payment Date set as September 9, 2026 with ratio of 50 tokens per common share owned as of end of business August 7, 2026 KareRx joint venture added Electronic Benefits Verification (EBV) and access to 200,000 patient lives that began to provide material revenue to rebranded Corexa Pharmacy Neuritek Therapeutics, Inc. pending acquisition was terminated in May 2026 TAMPA, FL / ACCESS Newswire / August 17, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today reported second quarter 2026 financials and provided a business update. The Company is expecting to launch the Health Lives Here (HLH) consumer app together with National Football League Alumni Health (NFLAH) in September 2026, targeting patients on or contemplating taking GLP-1 agonist medications in rural communities through their local independent pharmacies.

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026

TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today announced that its board of directors (the "Board") fixed September 9, 2026 (the "Payment Date") as the date on which the previously announced distribution (the "Distribution") of Dream Bowl Meme Coin I tokens (the "Dream Bowl Tokens") will be paid to record stockholders of DataMEDS (, the "Record Holders") as of the close of business on August 7, 2026 (the "Record Date"). The Record Holders will be entitled to receive fifty (50) Dream Bowl Tokens for each one (1) share of common stock of the Company ("Common Stock") held (or for each one (1) share of Common Stock issuable or deemed issuable upon exercise or conversion of such other eligible securities).

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026

DataMeds AI Provides Update on Corexa Health's Pharmacy Division

GLP-1 agonist drugs now available Integration of online store CorexaRx.com into Health Lives Here app now complete Medical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now available Revenue stabilized above $600,000 for July 2026 amid rebranding as pharmacy prepares to expand through the launch of Health Lives Here app with NFL Alumni Health TAMPA, FL / ACCESS Newswire / August 12, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant delivery of healthcare and monetization of health data by market participants, today provided an update on the Company's pharmaceuticals-focused subsidiary Corexa Health's pharmacy division Corexa Pharmacy. Corexa Pharmacy recently achieved several qualitative and quantitative milestones that position it to be the centerpiece of Company growth in the 2nd half of 2026.

DataMeds AI Provides Update on Corexa Health's Pharmacy Division

DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division

TAMPA, FL / ACCESS Newswire / August 10, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant monetization of health data by market participants, today announced that it has completed the name changes of its pharmacy and pharmacy hub subsidiaries to Corexa Pharmacy, LLC ("Corexa Pharmacy") and Corexa Tech & Hub, LLC ("Corexa Hub"), respectively. Corexa Pharmacy and Corexa Hub are themselves subsidiaries of the Company's newly renamed pharmacy-focused division Corexa Health, LLC.

DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division

DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date

TAMPA, FL / ACCESS Newswire / August 6, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant monetization of health data by market participants, today reiterated the August 7, 2026 record date for the 50:1 token to stock ratio for the Dream Bowl Meme Coin token (to DataMEDS common shares. The official platform for Dream Bowl Meme Coin tokens is https://www.biconomy.com/exchange/DREAM1_USDT.

DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date

DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"

Initiative with NFL Alumni Health is aimed at improving rural healthcare access by powering Health Lives Here consumer app that integrates Einstein AI with independent pharmacies and proprietary patient engagement tools TAMPA, FL / ACCESS Newswire / August 5, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," the "Company" or "DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the compliant monetization of health data by market participants, today announced that Interim Co-CEO Gerald Commissiong will be featured with a marquee NFL Hall of Famer with a significant social media following during segment on the Fox Business show "Claman Countdown" between 3pm and 4pm ET on August 5, 2026 to introduce the "Health Lives Here" initiative being advanced by the Company and National Football League Alumni Health ("NFLAH") to help improve rural access to healthcare. Health Lives Here is leveraging a subset of Company subsidiary Corexa Health's 6,500+ independent pharmacy network as physical vessels to for ongoing consumer education, emerging healthcare data capture technologies such as wearables and consumer applications, proprietary Tollo Health medical foods and supplements, and its Einstein artificial intelligence (AI) to drive improvements in healthcare outcomes.

DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"

DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets

Trading under new symbol (NASDAQ: MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ: WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide integrated solutions for the generation, rationalization, intervention, transaction and monetization of health data, today announced that it has officially completed its stock trading symbol change to ‘MEDS'. The Company began trading under the new stock symbol ‘MEDS' on the NASDAQ Capital Market stock exchange effective at the start of trading on Wednesday, July 22, 2026.

DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets

WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.

Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare Data TAMPA, Fla., July 21, 2026 /PRNewswire/ -- Wellgistics Health, Inc., (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it has officially completed its name change to DataMEDS AI, Inc. ("DataMEDS" or "the Company").

WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.

Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders

TAMPA, FL / ACCESS Newswire / July 20, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx™ artificial intelligence prescription drug routing into blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey, today announced an updated record date for the distribution of the Dream Bowl 2026 Meme Coin (https://www.biconomy.com/exchange/DREAM1_USDT) to Wellgistics stockholders. On December 3, 2025, Wellgistics announced that it would distribute one (1) Dream Bowl 2026 Meme Coin for every one (1) share of Wellgistics Health common stock held as of a designated record date.

Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders

See News Rankings

Price charts implemented using Lightweight Charts™